Healthtech Startups

1 investor

Autonomy Health provides AI tools and operational support for independent neurology private practices, automating back-office tasks such as insurance eligibility and benefits verification, prior authorizations, inbound fax routing, referral processing, scheduling, and billing. It also helps practices add revenue-generating service lines like in-office infusion suites, on-site imaging, in-house dispensing, and research programs.

1 investor

Jackie is an AI receptionist designed for NHS primary care practices that handles patient phone requests such as appointment bookings, repeat prescriptions, and triage submissions. It integrates directly with clinical systems and practice workflows to resolve administrative requests without human intervention.

1 investor

Aeris Biosciences (formerly Auxilium Health) develops biomaterials for regenerative medicine. The company is composed of scientists, engineers, and clinicians working in the human health field.

1 investor

Auxilius Pharma develops value-added cardiovascular medications by reformulating existing drugs into optimized dosage forms to improve patient outcomes. The company serves patients, healthcare providers, and payors by addressing unmet needs in cardiovascular health through enhanced drug delivery.

1 investor

1 investor

Avails Medical develops the eQUANT™ System, an FDA-cleared diagnostic platform using electronic biosensor technology for rapid antimicrobial susceptibility testing in infectious disease care. The system targets hospitals and clinical laboratories to accelerate diagnosis of infections like sepsis and combat antimicrobial resistance.

1 investor

Avalon provides diagnostic benefit management and analytics that turn diagnostic lab data into policy-driven, evidence-based decisions for health plans and payers, covering genetic, routine, oncology, and cardiometabolic testing. Its platform delivers real-time oversight of diagnostic ordering to reduce unnecessary testing costs and improve care.

1 investor

Avana Health is a women's health company developing uterine health treatments for abnormal uterine bleeding (AUB) and postpartum hemorrhage (PPH), and is preparing for its first clinical trials. Its treatments target unmet needs in maternal and gynecological care and are intended to be affordable and accessible to providers globally.

1 investor

Avania is a clinical development and regulatory consulting firm that supports medical device companies through product development, clinical trial execution, and FDA regulatory submissions. The company serves medtech innovators navigating complex regulatory pathways from early-stage concept to market clearance.

1 investor

Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection. The system targets research labs, clinical testing environments, and reference laboratories aiming to reduce manual labor and cost in precision oncology workflows.

1 investor

Avanta Grupo is an occupational health and workplace prevention provider that offers an external prevention service (Servicio de Prevención Ajeno) covering medical care, absenteeism management, nutrition programs, physiotherapy, and psychology/psychiatry for companies' employees. Serving employers in Spain, it focuses on preventive occupational health and employee wellbeing to improve workforce productivity.

1 investor

AvantGuard, a Cornell University spin-out originally founded as Halomine, develops N-halamine-based antimicrobial and surface-protection technology aimed at combating pathogens including the fungus Candida (Candidozyma) auris. The company is advancing an antifungal decolonization protocol toward FDA approval, targeting fungal skin and nail infections and healthcare antiseptic applications.

1 investor

Avantik provides integrated equipment, consumables, lab design services, and training for Mohs histology labs performing same-day surgical pathology. The company serves dermatologists and surgical pathology labs with cryostats, staining systems, and workflow optimization.

1 investor

VWR (part of Avantor) is a distributor of laboratory and production products and services, offering life science reagents, chemicals, lab equipment, consumables, safety/PPE, and furniture. It also provides procurement, supply chain, equipment servicing, and digital commerce/inventory software for research, biopharma, healthcare, and industrial customers.

1 investor

Avarie makes ultra-absorbent menstrual pads designed for heavy flow, tested with blood-consistency fluid rather than saline. The pads offer extended back coverage and an ultra-thin profile for women seeking reliable protection during heavy menstrual days.

1 investor

AVaTAR MedTech develops medical devices for aortic and pulmonary valve disease treatment, addressing surgical needs in underserved patient populations globally. The company combines advanced medical technology with cost-effective solutions to expand access to cardiac surgery procedures.

1 investor

Aveanna is a national home healthcare provider offering clinical and homecare services to children and adults across 39 states. The company emphasizes caregiver support, patient relationships, and technology-enabled care delivery.

1 investor

Avedian builds AI-powered software modules for hospitals, clinics, health insurers, and pharmaceutical companies to manage clinical operations, economic performance, data governance, and risk-sharing agreements. The platform serves Latin American healthcare organizations seeking to optimize clinical delivery, control costs, and automate administrative processes.

1 investor

Avenda Health develops Unfold AI, deep learning software that maps a patient's prostate cancer in 3D to give physicians visualization and information for treatment planning. The company serves urologists and physicians treating prostate cancer patients in the medical device and healthcare space.

1 investor

Aventera Antibodies is a preclinical biotech developing a first-in-class precision immunotherapy — an engineered monoclonal antibody — against invasive Group A Streptococcal (iGAS) infections, with first-in-human trials planned for 2028. The therapy is intended to be paired with rapid Strep-A diagnostics to enable early clinical intervention.

1 investor

AVEO, operating as a subsidiary of LG Chem, develops and commercializes oncology medicines aimed at cancer patients seeking effective treatments that maintain quality of life. The company operates a portfolio of on-market and in-development therapeutic products globally.

1 investor

Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.

1 investor

Avesta Bio is a biotech company developing cancer therapeutics by targeting oxidative stress and its role in disease, based on the approach of identifying what is common across cancer cells rather than what differs. Its research points to methods of killing many cancer cell types without harming normal cells, with potential applications to other metabolic diseases.

1 investor